Hacker NF; Moore JJ, 1998, Essentials of Obstetrics and Gynecology, Original, W B Saunders Company, Philadelphia USA

Hacker NF; Eifel PJ, 2014, 'Vulvar cancer', in Berek and Hacker's Gynecologic Oncology: Sixth Edition, pp. 560 - 607

Berek JS; Friedlander ML; Hacker NF, 2014, 'Epithelial ovarian, fallopian tube, and peritoneal cancer', in Berek and Hacker's Gynecologic Oncology: Sixth Edition, pp. 464 - 529

Hacker NF; Marsden DE, 2005, 'Surgery for uterine cancer', in Uterine Cancer, pp. 131 - 148

Hacker NF, 2000, 'Vaginal Cancer', in Practical Gynecologic Oncology, edn. Original, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 597 - 614

Hacker NF, 2000, 'TE', in Practical Gynecologic Oncology, edn. Original, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 553 - 596

Hacker NF; Beretov J, 2000, 'Nonepithelial Ovarian and Fallopian Tube Cancers', in Practical Gynecologic Oncology, edn. Original, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 523 - 552

Hacker NF, 2000, 'Uterine Cancer', in Practical Gynecologic Oncology, edn. Original, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 407 - 456

Hacker NF, 2000, 'Cervical Cancer', in Practical Gynecologic Oncology, edn. Original, Lippincott Williams OEM_sqlplus_input_finished, Philadelphia, USA, pp. 345 - 406

Hacker NF, 1998, 'Essentials of Obstetrics and Gynecology', in Essentials of Obstetrics and Gynecology, edn. Original, W B Saunders Company, Philadelphia USA, pp. 623 - 633

Friedlander ML; Gershenson D; Hacker NF; Arjun G; Smitj; Barber HM, 1997, 'Stage IIC ovarian cancer which is completely resected. In expert consultations in gynecological cancers.', in Stage IIC ovarian cancer which is completely resected. In expert consultations in gynecological cancers., edn. Original, Mercel Dekker, New York, pp. 263 - 270

Sartorius CM; Schoetzau A; Kettelhack H; Fink D; Hacker NF; Fedier A; Jacob F; Heinzelmann-Schwarz V, 2018, 'ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer', PLoS ONE, vol. 13, http://dx.doi.org/10.1371/journal.pone.0195213

Henry C; Hacker N; Ford C, 2017, 'Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis', Oncotarget, vol. 8, pp. 112727 - 112738, http://dx.doi.org/10.18632/oncotarget.22559

Hacker NF, 2017, 'Neoadjuvant chemotherapy for advanced epithelial ovarian cancer. Who really benefits?', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 57, pp. 585 - 587, http://dx.doi.org/10.1111/ajo.12737

Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH, 2017, 'Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma', Molecular Oncology, vol. 11, pp. 1595 - 1615, http://dx.doi.org/10.1002/1878-0261.12134

Kang YJ; Smith M; Barlow E; Coffey K; Hacker N; Canfell K, 2017, 'Vulvar cancer in high-income countries: Increasing burden of disease', International Journal of Cancer, vol. 141, pp. 2174 - 2186, http://dx.doi.org/10.1002/ijc.30900

Pokharel HP; Hacker NF; Andrews L, 2017, 'Hereditary gynaecologic cancers in Nepal: A proposed model of care to serve high risk populations in developing countries', Hereditary Cancer in Clinical Practice, vol. 15, http://dx.doi.org/10.1186/s13053-017-0072-y

Henry CE; Emmanuel C; Lambie N; Loo C; Kan B; Kennedy CJ; de Fazio A; Hacker NF; Ford CE, 2017, 'Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer', Translational Oncology, vol. 10, pp. 346 - 356, http://dx.doi.org/10.1016/j.tranon.2017.01.014

Hacker NF, 2017, 'Preface: Volume 41', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 41, pp. 1 - 2, http://dx.doi.org/10.1016/j.bpobgyn.2017.02.001

Pochechueva T; Alam S; Schötzau A; Chinarev A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V, 2017, 'Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients', Journal of Ovarian Research, vol. 10, http://dx.doi.org/10.1186/s13048-017-0305-8

Hacker NF; Rao A, 2017, 'Surgery for advanced epithelial ovarian cancer', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 41, pp. 71 - 87, http://dx.doi.org/10.1016/j.bpobgyn.2016.10.007

Pokharel HP; Hacker NF; Andrews L, 2016, 'Genetic testing in a gynaecological oncology care in developing countries-knowledge, attitudes and perception of Nepalese clinicians.', Gynecol Oncol Res Pract, vol. 3, pp. 12, http://dx.doi.org/10.1186/s40661-016-0034-5

Pochechueva T; Chinarev A; Schoetzau A; Fedier A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V, 2016, 'Blood plasma-derived anti-glycan antibodies to sialylated and sulfated glycans identify ovarian cancer patients', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0164230

Pokharel HP; Hacker NF; Andrews L, 2016, 'Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 56, pp. 633 - 638, http://dx.doi.org/10.1111/ajo.12504

Manegold-Brauer G; Buechel J; Knipprath-Mészaros A; Schoetzau A; Hacker NF; Tercanli S; Lapaire O; Heinzelmann-Schwarz V, 2016, 'Improved Detection Rate of Ovarian Cancer Using a 2-Step Triage Model of the Risk of Malignancy Index and Expert Sonography in an Outpatient Screening Setting', International Journal of Gynecological Cancer, vol. 26, pp. 1062 - 1069, http://dx.doi.org/10.1097/IGC.0000000000000718

Henry CE; Llamosas E; Djordjevic A; Hacker NF; Ford CE, 2016, 'Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer.', Oncogenesis, vol. 5, pp. e226, http://dx.doi.org/10.1038/oncsis.2016.32

Henry C; Llamosas E; Djordjevic A; Hacker N; Ford C, 2016, 'Targeting the RB-E2F pathway in breast cancer', Oncogene, http://dx.doi.org/10.1038/onc.2016.32

Hacker NF; Eifel PJ; Van Der Velden J, 2016, 'Erratum: Cancer of the vulva (International Journal of Gynecology and Obstetrics (2015) 131:Suppl 2 (S76-S83))', International Journal of Gynecology and Obstetrics, vol. 132, pp. 365, http://dx.doi.org/10.1016/j.ijgo.2015.12.001

Ford CE; Henry C; Llamosas E; Djordjevic A; Hacker N, 2016, 'Wnt signalling in gynaecological cancers: A future target for personalised medicine?', Gynecologic Oncology, vol. 140, pp. 345 - 351, http://dx.doi.org/10.1016/j.ygyno.2015.09.085

Barlow E; King K; Farrell R; Watts S; Rao A; Robertson G; Sayer R; Hacker N, 2015, 'Outcomes following the implementation of an enhanced recovery program in gynaecological oncology', International Journal of Gynaecological cancer, vol. 25, pp. 344 - 344

Kondrashova O; Love CJ; Lunke S; Hsu AL; Bowtell D; Chenevix-Trench G; Green A; Webb P; DeFazio A; Gertig D, 2015, 'High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0143006

Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW, 2015, 'Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer', Oncotarget, vol. 6, pp. 44551 - 44562, http://dx.doi.org/10.18632/oncotarget.6082

Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R, 2015, 'Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion', Oncotarget, vol. 6, pp. 40310 - 40326, http://dx.doi.org/10.18632/oncotarget.5643

Barlow EL; Kang YJ; Hacker NF; Canfell K, 2015, 'Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia since 1982', International Journal of Gynecological Cancer, vol. 25, pp. 1683 - 1689, http://dx.doi.org/10.1097/IGC.0000000000000547

Hacker NF; Eifel PJ; Van Der Velden J, 2015, 'Cancer of the vulva', International Journal of Gynecology and Obstetrics, vol. 131, pp. S76 - S83, http://dx.doi.org/10.1016/j.ijgo.2015.06.002

Hacker NF; Eifel PJ; Van Der Velden J, 2015, 'Cancer of the vagina', International Journal of Gynecology and Obstetrics, vol. 131, pp. S84 - S87, http://dx.doi.org/10.1016/j.ijgo.2015.06.003

Hacker NF; Barlow EL, 2015, 'Staging for vulvar cancer', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 29, pp. 802 - 811, http://dx.doi.org/10.1016/j.bpobgyn.2015.01.004

Scurry J; Hacker NF; Barlow E; Friedlander M; Jackson M, 2015, 'Is quantification of lymphovascular space invasion useful in stage 1B2 cervical carcinomas?', Journal of Obstetrics and Gynaecology, vol. 35, pp. 377 - 381, http://dx.doi.org/10.3109/01443615.2014.958448

Peculis LD; Ius Y; Campion M; Friedlander M; Hacker N, 2015, 'Stage IB2 adenosquamous cervical cancer diagnosed at 19-weeks' gestation', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 55, pp. 94 - 97, http://dx.doi.org/10.1111/ajo.12281

Kang Y-J; O'Connell DL; Tan J; Lew J-B; Demers A; Lotocki R; Kliewer EV; Hacker NF; Jackson M; Delaney GP, 2014, 'Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities', Cancer Epidemiology, http://dx.doi.org/10.1016/j.canep.2015.04.009

Peculis LD; Ius Y; Campion M; Friedlander M; Hacker N, 2014, 'Stage IB2 adenosquamous cervical cancer diagnosed at 19-weeks gestation', Australian and New Zealand Journal of Obstetrics and Gynaecology, http://dx.doi.org/10.1111/ajo.12281

Barlow EL; Kang YJ; Hacker NF; Canfell K, 2014, 'TRENDS IN THE INCIDENCE AND MORTALITY OF VULVAR CANCER IN AUSTRALIA', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 24, pp. 900 - 900, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966501334&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA, 2014, 'Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells', BMC Molecular Biology, vol. 15, http://dx.doi.org/10.1186/1471-2199-15-24

Jacob F; Anugraham M; Pochechueva T; Tse BWC; Alam S; Guertler R; Bovin NV; Fedier A; Hacker NF; Huflejt ME, 2014, 'The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration', British Journal of Cancer, vol. 111, pp. 1634 - 1645, http://dx.doi.org/10.1038/bjc.2014.455

Tracey E; Hacker NF; Young J; Armstrong BK, 2014, 'Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: A data linkage study', International Journal of Gynecological Cancer, vol. 24, pp. 1232 - 1240, http://dx.doi.org/10.1097/IGC.0000000000000213

Barlow EL; Hacker NF; Hussain R; Parmenter G, 2014, 'Sexuality and body image following treatment for early-stage vulvar cancer: A qualitative study', Journal of Advanced Nursing, vol. 70, pp. 1856 - 1866, http://dx.doi.org/10.1111/jan.12346

Warton K; Lin V; Navin T; Armstrong NJ; Kaplan W; Ying K; Gloss B; Mangs H; Nair SS; Hacker NF, 2014, 'Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma', BMC Genomics, vol. 15, http://dx.doi.org/10.1186/1471-2164-15-476

Jacob F; Nixdorf S; Hacker NF; Heinzelmann-Schwarz VA, 2014, 'Reliable in vitro studies require appropriate ovarian cancer cell lines', Acta Veterinaria Scandinavica, pp. 60 - 60, http://dx.doi.org/10.1186/1757-2215-7-60

Gao B; Russell A; Beesley J; Chen XQ; Healey S; Henderson M; Wong M; Emmanuel C; Galletta L; Johnatty SE, 2014, 'Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer', Scientific Reports, vol. 4, http://dx.doi.org/10.1038/srep04669

Farrell R; Gebski V; Hacker NF, 2014, 'Quality of life after complete lymphadenectomy for vulvar cancer: Do women prefer sentinel lymph node biopsy?', International Journal of Gynecological Cancer, vol. 24, pp. 813 - 819, http://dx.doi.org/10.1097/IGC.0000000000000101

Heinzelmann-Schwarz VA; Nixdorf S; Valadan M; Diczbalis M; Olivier J; Otton G; Fedier A; Hacker NF; Scurry JP, 2014, 'A clinicopathological review of 33 patients with vulvar melanoma identifies c-KIT as a prognostic marker', International Journal of Molecular Medicine, vol. 33, pp. 784 - 794, http://dx.doi.org/10.3892/ijmm.2014.1659

Gloss B; Moran-Jones K; Lin V; Gonzalez M; Scurry J; Hacker NF; Sutherland RL; Clark SJ; Samimi G, 2014, 'ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer', Molecular Cancer, vol. 13, http://dx.doi.org/10.1186/1476-4598-13-3

Hacker NF; Barlow EL; Scurry J; Gebski V; Farrell R; Robertson G; Friedlander ML; Jackson M, 2013, 'Primary surgical management with tailored adjuvant radiation for stage IB2 cervical cancer', Obstetrics and Gynecology, vol. 121, pp. 765 - 772, http://dx.doi.org/10.1097/AOG.0b013e3182887836

Warton K; Vita L; Armstrong NJ; Kaplan W; Ying K; Mangs H; Hacker NF; Sutherland RL; Clark SJ; Samimi G, 2013, 'Whole genome sequencing of free circulating DNA from plasma of HGSOC patients', CLINICAL CANCER RESEARCH, vol. 19, http://dx.doi.org/10.1158/1078-0432.OVCA13-A4

Hacker NF, 2013, 'State of the art of surgery in advanced epithelial ovarian cancer', Annals of Oncology, vol. 24, http://dx.doi.org/10.1093/annonc/mdt465

McCluggage WG; Colgan T; Duggan M; Hacker NF; Mulvany N; Otis C; Wilkinson N; Zaino RJ; Hirschowitz L, 2013, 'Data set for reporting of endometrial carcinomas: Recommendations from the international collaboration on cancer reporting (ICCR) between United Kingdom, United States, Canada, and Australasia', International Journal of Gynecological Pathology, vol. 32, pp. 45 - 65, http://dx.doi.org/10.1097/PGP.0b013e31825d808b

Jacob F; Guertler R; Naim S; Nixdorf S; Fedier A; Hacker NF; Heinzelmann-Schwarz V, 2013, 'Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0059180

Hacker NF; Eifel PJ; Van Der Velden J, 2012, 'Cancer of the vagina', International Journal of Gynecology and Obstetrics, vol. 119, http://dx.doi.org/10.1016/S0020-7292(12)60022-8

Denny L; Quinn M; Hacker N, 2012, 'FIGO cancer report 2012', International Journal of Gynecology and Obstetrics, vol. 119, http://dx.doi.org/10.1016/S0020-7292(12)00458-4

Hacker NF; Eifel PJ; Van Der Velden J, 2012, 'Cancer of the vulva', International Journal of Gynecology and Obstetrics, vol. 119, http://dx.doi.org/10.1016/S0020-7292(12)60021-6

Maringe C; Walters S; Butler J; Coleman MP; Hacker N; Hanna L; Mosgaard BJ; Nordin A; Rosen B; Engholm G, 2012, 'Stage at diagnosis and ovarian cancer survival: Evidence from the international cancer benchmarking partnership', Gynecologic Oncology, vol. 127, pp. 75 - 82, http://dx.doi.org/10.1016/j.ygyno.2012.06.033

Hacker NF, 2012, 'Foreword', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 26, pp. 291 - 292, http://dx.doi.org/10.1016/j.bpobgyn.2012.01.003

Samimi G; Ring BZ; Ross DT; Seitz RS; Sutherland RL; O'Brien PM; Hacker NF; Huh WK, 2012, 'TLE3 expression is associated with sensitivity to taxane treatment in ovarian carcinoma', Cancer Epidemiology Biomarkers and Prevention, vol. 21, pp. 273 - 279, http://dx.doi.org/10.1158/1055-9965.EPI-11-0917

Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry JP; Guertler R; Hornung D; Mueller R, 2012, 'Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients', PLoS ONE, vol. 7, http://dx.doi.org/10.1371/journal.pone.0031885

Gloss BS; Patterson KI; Barton CA; Gonzalez M; Scurry JP; Hacker NF; Sutherland RL; O'Brien PM; Clark SJ, 2012, 'Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers', Cancer Letters, vol. 318, pp. 76 - 85, http://dx.doi.org/10.1016/j.canlet.2011.12.003

Montavon C; Gloss BS; Warton K; Barton CA; Statham AL; Scurry JP; Tabor B; Nguyen TV; Qu W; Samimi G, 2012, 'Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer', Gynecologic Oncology, vol. 124, pp. 582 - 588, http://dx.doi.org/10.1016/j.ygyno.2011.11.026

Hacker NF, 2011, 'Quality control in ovarian cancer surgery', Annals of Oncology, vol. 22, pp. 19 - 22, http://dx.doi.org/10.1093/annonc/mdr517

Jacob F; Meier M; Caduff R; Goldstein D; Pochechueva T; Hacker N; Fink D; Heinzelmann-Schwarz V, 2011, 'No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting', Gynecologic Oncology, vol. 121, pp. 487 - 491, http://dx.doi.org/10.1016/j.ygyno.2011.02.022

Pochechueva T; Jacob F; Heinzelmann-Schwarz V; Goldstein DR; Huflejt ME; Chinarev A; Bovin NV; Caduff R; Fink D; Hacker N, 2011, 'Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies', Glycoconjugate Journal, pp. 1 - 11, http://dx.doi.org/10.1007/s10719-011-9349-y

Pochechueva T; Jacob F; Goldstein DR; Huflejt ME; Chinarev A; Caduff R; Fink D; Hacker N; Bovin NV; Heinzelmann-Schwarz V, 2011, 'Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies', Glycoconjugate Journal, vol. 28, pp. 507 - 517, http://dx.doi.org/10.1007/s10719-011-9349-y

Hacker NF, 2011, 'Quality control in ovarian cancer surgery', Annals of Oncology, vol. 22, pp. viii19 - viii22

Barton CA; Gloss BS; Qu W; Statham AL; Hacker NF; Sutherland RL; Clark SJ; O'Brien PM, 2010, 'Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival', British Journal of Cancer, vol. 102, pp. 87 - 96, http://dx.doi.org/10.1038/sj.bjc.6605429

Byrne JA; Maleki S; Hardy JR; Gloss BS; Murali R; Scurry JP; Fanayan S; Emmanuel C; Hacker NF; Sutherland RL, 2010, 'MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome', BMC Cancer, vol. 10, http://dx.doi.org/10.1186/1471-2407-10-497

Pearce CL; Near AM; Van Den Berg DJ; Ramus SJ; Gentry-Maharaj A; Menon U; Gayther SA; Anderson AR; Edlund CK; Wu AH, 2009, 'Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium', British Journal of Cancer, vol. 100, pp. 412 - 420, http://dx.doi.org/10.1038/sj.bjc.6604820

Tracey EA; Roder DM; Francis J; Zorbas HM; Hacker NF; Bishop JF, 2009, 'Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003 implications for cancer control', International Journal of Gynecological Cancer, vol. 19, pp. 591 - 599, http://dx.doi.org/10.1111/IGC.0b013e3181a3a436

Hacker NF; Tantipalakorn C; Robertson G; Marsden DE; Gebski V, 2009, 'Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages i and II squamous cell vulvar cancer', Obstetrics and Gynecology, vol. 113, pp. 895 - 901, http://dx.doi.org/10.1097/AOG.0b013e31819b413f

Hacker NF, 2009, 'Revised FIGO staging for carcinoma of the vulva', International Journal of Gynecology and Obstetrics, vol. 105, pp. 105 - 106, http://dx.doi.org/10.1016/j.ijgo.2009.02.011

Tracey E; Roder D; Francis J; Zorbas H; Hacker NF; Bishop J, 2009, 'Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003', International Journal of Gynecological Cancer, vol. 19, pp. 591 - 599

Barton CA; Clark SJ; Hacker NF; O'Brien PM, 2008, 'Epigenetic markers of ovarian cancer', Advances in Experimental Medicine and Biology, vol. 622, pp. 35 - 51, http://dx.doi.org/10.1007/978-0-387-68969-2_4

Merritt MA; Green AC; Nagle CM; Webb PM; Bowtell D; Chenevix-Trench G; Green A; Webb P; DeFazio A; Gertig D, 2008, 'Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer', International Journal of Cancer, vol. 122, pp. 170 - 176, http://dx.doi.org/10.1002/ijc.23017

Barton CA; Hacker NF; Clark SJ; O'Brien PM, 2008, 'DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment', Gynecologic Oncology, vol. 109, pp. 129 - 139, http://dx.doi.org/10.1016/j.ygyno.2007.12.017

Ramus SJ; Vierkant RA; Johnatty SE; Pike MC; Van Den Berg DJ; Wu AH; Pearce CL; Menon U; Gentry-Maharaj A; Gayther SA, 2008, 'Consortium analysis of 7 candidate SNPs for ovarian cancer', International Journal of Cancer, vol. 123, pp. 380 - 388, http://dx.doi.org/10.1002/ijc.23448

Olsen CM; Nagle CM; Whiteman DC; Purdie DM; Green AC; Webb PM; Bowtell D; Chenevix-Trench G; Green A; DeFazio A, 2008, 'Body size and risk of epithelial ovarian and related cancers: A population-based case-control study', International Journal of Cancer, vol. 123, pp. 450 - 456, http://dx.doi.org/10.1002/ijc.23509

Hacker NF; Valmadre S; Robertson G, 2008, 'Management of retroperitoneal lymph nodes in advanced ovarian cancer', International Journal of Gynecological Cancer, vol. 18, pp. 7 - 10, http://dx.doi.org/10.1111/j.1525-1438.2007.01097.x

Chia YN; Marsden DE; Robertson G; Hacker NF, 2008, 'Triage of ovarian masses', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 48, pp. 322 - 328, http://dx.doi.org/10.1111/j.1479-828X.2008.00825.x

O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro', British Journal of Cancer, vol. 98, pp. 1085 - 1093, http://dx.doi.org/10.1038/sj.bjc.6604281

O'Brien PM; Davies MJ; Scurry JP; Smith AN; Barton CA; Henderson MJ; Saunders DN; Gloss BS; Patterson KI; Clancy JL, 2008, 'The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro (British Journal of Cancer (2008) 98, (1085-1093) DOI: 10.1', British Journal of Cancer, vol. 98, pp. 1880, http://dx.doi.org/10.1038/sj.bjc.6604419

Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; Bowtell D; Chenevix-Trench G; Green A; Webb P; DeFazio A, 2008, 'Skewed X chromosome inactivation and breast and ovarian cancer status: Evidence for X-linked modifiers of BRCA1', Journal of the National Cancer Institute, vol. 100, pp. 1519 - 1529, http://dx.doi.org/10.1093/jnci/djn345

Hyde SE; Valmadre S; Hacker NF; Schilthuis MS; Grant PT; Van Der Velden J, 2007, 'Squamous cell carcinoma of the vulva with bulky positive groin nodes - Nodal debulking versus full groin dissection prior to radiation therapy', International Journal of Gynecological Cancer, vol. 17, pp. 154 - 158, http://dx.doi.org/10.1111/j.1525-1438.2006.00769.x

Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N, 2007, 'Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma', Gynecologic Oncology, vol. 106, pp. 44 - 51, http://dx.doi.org/10.1016/j.ygyno.2007.01.054

Olsen CM; Bain CJ; Jordan SJ; Nagle CM; Green AC; Whiteman DC; Webb PM; Bowtell D; Chenevix-Trench G; Green A, 2007, 'Recreational physical activity and epithelial ovarian cancer: A case-control study, systematic review, and meta-analysis', Cancer Epidemiology Biomarkers and Prevention, vol. 16, pp. 2321 - 2330, http://dx.doi.org/10.1158/1055-9965.EPI-07-0566

Beesley J; Jordan SJ; Spurdle AB; Song H; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; McGuire V; Whittemore AS, 2007, 'Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: Results from two Australian studies and an additional validation set', Cancer Epidemiology Biomarkers and Prevention, vol. 16, pp. 2557 - 2565, http://dx.doi.org/10.1158/1055-9965.EPI-07-0542

Eden JA; Hacker NF; Fortune M, 2007, 'Three cases of endometrial cancer associated with "bioidentical" hormone replacement therapy', Medical Journal of Australia, vol. 187, pp. 244 - 245

Heinzelmann-Schwarz VA; Scolyer RA; Scurry JP; Smith AN; Gardiner-Garden M; Biankin AV; Baron-Hay S; Scott C; Ward RL; Fink D, 2007, 'Low meprin α expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries', Journal of Clinical Pathology, vol. 60, pp. 622 - 626, http://dx.doi.org/10.1136/jcp.2005.034223

Matsuura Y; Robertson G; Marsden DE; Kim SN; Gebski V; Hacker NF, 2007, 'Thromboembolic complications in patients with clear cell carcinoma of the ovary', Gynecologic Oncology, vol. 104, pp. 406 - 410, http://dx.doi.org/10.1016/j.ygyno.2006.08.026

Galundiuk S; Webb M; Shepherd J; Knoefel W; Peltecu G; Maggioni A; Hacker NF; Trope C; Querleu D, 2007, 'An international perspective on surgical health care and education', Journal of the American College of Surgeons, vol. 204, pp. 148 - 157

Fink D; Chetty N; Lehm JP; Marsden DE; Hacker NF, 2006, 'Hyperbaric oxygen therapy for delayed radiation injuries in gynecological cancers', International Journal of Gynecological Cancer, vol. 16, pp. 638 - 642, http://dx.doi.org/10.1111/j.1525-1438.2006.00388.x

Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry JP; Scolyer RA; Smith AN; Bali A; Vanden Bergh P; Baron-Hay S; Scott C, 2006, 'A distinct molecular profile associated with mucinous epithelial ovarian cancer', British Journal of Cancer, vol. 94, pp. 904 - 913, http://dx.doi.org/10.1038/sj.bjc.6603003

Scurry J; Campion M; Scurry B; Kim SN; Hacker N, 2006, 'Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia', International Journal of Gynecological Pathology, vol. 25, pp. 176 - 181, http://dx.doi.org/10.1097/01.pgp.0000189238.19027.df

Matsuura Y; Robertson G; Marsden DE; Kim S; Gebski V; Hacker NF, 2006, 'Thromboembolic complications in patients with clear cell carcinoma of the ovary', Gynecologic Oncology, pp. 1 - 5

Hyde SE; Valmadre S; Hacker NF; Schilthuis MS; Grant PT; Van Der Velden J, 2006, 'Squamous cell carcinoma of the vulva with bulky position groin nodes - nodal debulking versus full groin dissection prior to radiation therapy', International Journal of Gynecological Cancer, pp. 1 - 8

Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S, 2005, 'Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: A randomized clinical trial', Journal of the National Cancer Institute, vol. 97, pp. 560 - 566, http://dx.doi.org/10.1093/jnci/dji102

Farrell R; Scurry J; Otton G; Hacker NF, 2005, 'Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium', Gynecologic Oncology, vol. 98, pp. 254 - 262, http://dx.doi.org/10.1016/j.ygyno.2005.03.044

Berek JS; Howe C; Lagasse LD; Hacker NF, 2005, 'Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA', Gynecologic Oncology, vol. 99, pp. 153 - 159, http://dx.doi.org/10.1016/j.ygyno.2005.05.034

Morice P; Pautier P; Lhommé C; Castaigne D; Querleu D; Ferron G; Panici PB; Angioli R; Manci N; Landoni F, 2005, 'Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: A randomized clinical trial (multiple letters) [2]', Journal of the National Cancer Institute, vol. 97, pp. 1620 - 1622, http://dx.doi.org/10.1093/jnci/dji347

Steigrad S; Hacker NF; Kolb B, 2005, 'In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy', Fertility and Sterility, vol. 83, pp. 1547.e7 - 1547.e9, http://dx.doi.org/10.1016/j.fertnstert.2005.01.093

Lataifeh I; Marsden DE; Robertson G; Gebski V; Hacker NF, 2005, 'Presenting symptoms of epithelial ovarian cancer', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 45, pp. 211 - 214, http://dx.doi.org/10.1111/j.1479-828X.2005.00391.x

Pack SD; Alper OM; Stromberg K; Augustus M; Özdemirli M; Miermont AM; Klus G; Rusin M; Slack R; Hacker NF, 2004, 'Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line', Cancer Research, vol. 64, pp. 789 - 794, http://dx.doi.org/10.1158/0008-5472.CAN-03-1982

Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM, 2004, 'Cyclin D1, p53, and p21^Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer', Clinical Cancer Research, vol. 10, pp. 5168 - 5177, http://dx.doi.org/10.1158/1078-0432.CCR-03-0751

Zhang Z; Bast RC; Yu Y; Li J; Sokoll LJ; Rai AJ; Rosenzweig JM; Cameron B; Wang YY; Meng XY, 2004, 'Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer', Cancer Research, vol. 64, pp. 5882 - 5890, http://dx.doi.org/10.1158/0008-5472.CAN-04-0746

Fink D; Marsden DE; Edwards L; Camaris C; Hacker NF, 2004, 'Malignant perivascular epithelioid cell tumor (PEComa) arising in the broad ligament', International Journal of Gynecological Cancer, vol. 14, pp. 1036 - 1039, http://dx.doi.org/10.1111/j.1048-891X.2004.014549.x

Bast R; Yu Y; Li J; Sokoll L; Rai A; Rosenzweig J; Cameron B; Wang Y; Berchuck A; Van Haaften-Day C, 2004, 'Serum proteomics yield new biomarkers for ovarian cancer', Cancer Biology and Therapy, vol. 3, pp. 794 - 795

Hacker NF; Friedlander M, 2004, 'Treatment of recurrent ovarian cancer', Chang Gung Medical Journal, vol. 27, pp. 570 - 577

Heinzelmann-Schwarz VA; Gardiner-Garden M; Henshall SM; Scurry J; Scolyer RA; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG, 2004, 'Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer', Clinical Cancer Research, vol. 10, pp. 4427 - 4436, http://dx.doi.org/10.1158/1078-0432.CCR-04-0073

Quinn DI; Henshall SM; Davies MJ; Heinzelmann-Schwarz V; Watts CK; Sutherland RL; Hacker NF; O Brien P, 2004, 'Overexpression of the human hyperplastic discs protein EDD is anindependent predictor of relapse in serous epithelial ovarian cancer', Journal of Clinical Oncology, vol. 22, pp. 463S - 463S

Heinzelmann-Schwarz V; Gardiner-Garden M; Henshall SM; Scurry JP; Scolyer R; Davies MJ; Heinzelmann M; Kalish LH; Bali A; Kench JG, 2004, 'Overexpresion of the Cell Adhesion Molecules DDR1, Claudin 3. and Ep-CAM in Metaplastic Ovarian Epithelium and Ovarian Cancer', Clinical Cancer Research, vol. 10

Concin N; Hefler L; Van Bavel J; Mueller-Holzner E; Zeimet A; Daxenbichler G; Speiser P; Hacker N; Marth C, 2003, 'Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases', Gynecologic Oncology, vol. 89, pp. 9 - 15, http://dx.doi.org/10.1016/S0090-8258(02)00147-6

Juraskova I; Butow P; Robertson R; Sharpe L; McLeod C; Hacker N, 2003, 'Post-treatment sexual adjustment following cervical and endometrial cancer: A qualitative insight', Psycho-Oncology, vol. 12, pp. 267 - 279, http://dx.doi.org/10.1002/pon.639

Shannon C; Kirk J; Barnetson R; Evans J; Schnitzler M; Quinn M; Hacker N; Crandon A; Harnett P, 2003, 'Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium', Clinical Cancer Research, vol. 9, pp. 1387 - 1392

Clancy JL; Henderson MJ; Russell AJ; Anderson DW; Bova RJ; Campbell IG; Choong DYH; Macdonald GA; Mann GJ; Nolan T, 2003, 'EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer', Oncogene, vol. 22, pp. 5070 - 5081, http://dx.doi.org/10.1038/sj.onc.1206775

Kohlberger P; Edwards L; Hacker NF, 2003, 'Microinvasive squamous cell carcinoma of the cervix: Immunohistochemically detected prognostic factors in a case with poor clinical outcome', Gynecologic Oncology, vol. 90, pp. 443 - 445, http://dx.doi.org/10.1016/S0090-8258(03)00250-6

Marsden DE; Hacker NF, 2003, 'The classification, diagnosis and management of endometrial hyperplasia', Reviews in Gynaecological Practice, vol. 3, pp. 89 - 97, http://dx.doi.org/10.1016/S1471-7697(03)00046-7

Hacker NF, 2003, 'Cervical Cancer- One Disease Worlds Apart', Australasian Journal of Cancer, vol. 2, pp. 71 - 72

Hacker NF, 2003, 'Screening for Cervical Cancer in Australia- the way forward', Australasian Journal of General Practice, vol. 3, pp. 6 - 7

Tay EH; Grant PT; Gebski V; Hacker NF, 2002, 'Secondary cytoreduction surgery for recurrent epithelial ovarian cancer', Obstetrics and Gynecology, vol. 100, pp. 1360

Marsden DE; Hacker NF, 2002, 'Urinary problems following simple and radical vulvectomy', CME Journal of Gynecologic Oncology, vol. 7, pp. 61 - 64

Tay EH; Grant PT; Gebski V; Hacker NF, 2002, 'Secondary cytoreductive surgery for recurrent epithelial ovarian cancer', Obstetrics and Gynecology, vol. 99, pp. 1008 - 1013, http://dx.doi.org/10.1016/S0029-7844(02)01977-4

Marsden DE; Hacker NF, 2002, 'Management of intraoperative gastrointestinal injuries', CME Journal of Gynecologic Oncology, vol. 7, pp. 194 - 197

Farghaly SA; Tay EH; Grant PT; Gebski V; Hacker NF, 2002, 'Secondary cytoreduction surgery for recurrent epithelial ovarian cancer [6] (multiple letters)', Obstetrics and Gynecology, vol. 100, pp. 1359 - 1360

van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HW; van der Zee AG; Bast RC; Hacker NF, 2001, 'OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.', Cancer, vol. 92, pp. 2837 - 2844, http://dx.doi.org/10.1002/1097-0142(20011201)92:11<2837::aid-cncr10093>3.0.co;2-5

Marx GM; Friedlander ML; Hacker NF, 2001, 'Cytotoxic drug treatment of vulval and vaginal cancer', CME Journal of Gynecologic Oncology, vol. 6, pp. 67 - 72

Pribill I; Speiser P; Leary J; Leodolter S; Hacker NF; Friedlander ML; Birnbaum D; Zeillinger R; Krainer M, 2001, 'High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma', Cancer Genetics and Cytogenetics, vol. 129, pp. 23 - 29, http://dx.doi.org/10.1016/S0165-4608(01)00419-8

Marsden DE; Hacker NF, 2001, 'Controversies and new trends in staging vulval and vaginal carcinoma', CME Journal of Gynecologic Oncology, vol. 6, pp. 235 - 239

Manolitsas TP; Wain GV; Williams KE; Freidlander M; Hacker NF, 2001, 'Multimodality therapy for patients with clinical stage I and II malignant mixed Müllerian tumors of the uterus', Cancer, vol. 91, pp. 1437 - 1443, http://dx.doi.org/10.1002/1097-0142(20010415)91:8<1437::AID-CNCR1150>3.0.CO;2-P

Lickiss JN; Hacker NF, 2001, 'Care of the patient close to death', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 15, pp. 333 - 340, http://dx.doi.org/10.1053/beog.2000.0173

Marsden DE; Lickiss JN; Hacker NF, 2001, 'Gastrointestinal problems in patients with advanced gynaecological malignancy', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 15, pp. 253 - 263, http://dx.doi.org/10.1053/beog.2000.0166

Marsden DE; Hacker NF, 2001, 'Optimal management of endometrial hyperplasia', Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 15, pp. 393 - 405, http://dx.doi.org/10.1053/beog.2000.0184

Alper O; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG, 2001, 'Epidermal growth factor receptor signalling and the invasive phenotype of ovarian carcinoma cells', Journal of the National Cancer Institute, vol. 93, pp. 1375 - 1384, http://dx.doi.org/10.1093/jnci/93.18.1375

Grumann M; Robertson R; Hacker NF; Sommer G, 2001, 'Sexual functioning in patients following radical hysterectomy for stage IB cancer of the cervix', International Journal of Gynecological Cancer, vol. 11, pp. 372 - 380, http://dx.doi.org/10.1046/j.1525-1438.2001.01051.x

van Haaften-Day C; Shen Y; Xu F; Yu Y; Berchuck A; Havrilesky LJ; de Bruijn HWA; van der Zee AGJ; Bast RC; Hacker NF, 2001, 'OVXL, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma a critical appraisal', Cancer, vol. 92, pp. 2837 - 2844, http://dx.doi.org/10.1002/1097-0142(20011201)92:11<2837::AID-CNCR10093>3.0.CO;2-5

Marsden DE; Hacker NF, 2001, 'Contemporary management of primary carcinoma of the vulva', Surgical Clinics of North America, vol. 81, pp. 799 - 813, http://dx.doi.org/10.1016/S0039-6109(05)70166-3

Krishnan CS; Grant PT; Robertson G; Hacker NF, 2001, 'Lymphatic ascites following lymphadenectomy for gynecological malignancy', International Journal of Gynecological Cancer, vol. 11, pp. 392 - 396, http://dx.doi.org/10.1046/j.1525-1438.2001.01050.x

Hacker NF, 2001, 'Stage IB2 Cervical Cancer a Philosophy of Management', Research Advances and Research Updates, vol. 2, No: 1, pp. 94 - 99

Sanson-Fisher R; Girgis A; Boyes A; Bonevski B; Burton L; Cook P; Ackland S; Baker R; Berry M; Biggs J, 2000, 'The unmet supportive care needs of patients with cancer', Cancer, vol. 88, pp. 225 - 236

Bonevski B; Sanson-Fisher R; Girgis A; Burton L; Cook P; Boyes A; Ackland S; Baker R; Berry M; Biggs J, 2000, 'Evaluation of an instrument to assess the needs of patients with cancer', Cancer, vol. 88, pp. 217 - 225, http://dx.doi.org/10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y

Marsden DE; Friedlander M; Hacker NF, 2000, 'Current management of epithelial ovarian carcinoma: A review', Seminars in Surgical Oncology, vol. 19, pp. 11 - 19, http://dx.doi.org/10.1002/1098-2388(200007/08)19:1<11::AID-SSU3>3.0.CO;2-3

Low JJH; Perrin LC; Crandon AJ; Hacker NF, 2000, 'Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors: A review of 74 cases', Cancer, vol. 89, pp. 391 - 398, http://dx.doi.org/10.1002/1097-0142(20000715)89:2<391::AID-CNCR26>3.0.CO;2-V

Thuis YN; Campion M; Fox H; Hacker NF, 2000, 'Contemporary experience with the management of vulvar intraepithelial neoplasia', International Journal of Gynecological Cancer, vol. 10, pp. 223 - 227, http://dx.doi.org/10.1046/j.1525-1438.2000.010003223.x

Alper O; De Santis ML; Stromberg K; Hacker NF; Cho-Chung YS; Salomon DS, 2000, 'Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells', International Journal of Cancer, vol. 88, pp. 566 - 574, http://dx.doi.org/10.1002/1097-0215(20001115)88:4<566::AID-IJC8>3.0.CO;2-D

Kohlberger PD; Edwards L; Collins C; Milross C; Hacker NF, 2000, 'Laparoscopic port-site recurrence following surgery for a stage IB squamous cell carcinoma of the cervix with negative lymph nodes', Gynecologic Oncology, vol. 79, pp. 324 - 326, http://dx.doi.org/10.1006/gyno.2000.5932

Speiser P; Kridelka F; Tempfer C; Edwards L; Leodolter S; Kainz C; Hacker NF, 1999, 'CD44v6 expression is an independent prognostic factor in node-negative FIGO stage IB cervical carcinoma', International Journal of Gynecological Cancer, vol. 9, pp. 160 - 165, http://dx.doi.org/10.1046/j.1525-1438.1999.09913.x

Hacker NF, 1999, 'Radical resection of vulvar malignancies: A paradigm shift in surgical approaches', Current Opinion in Obstetrics and Gynecology, vol. 11, pp. 61 - 64, http://dx.doi.org/10.1097/00001703-199901000-00011

Ishioka SI; Van Haaften-Day C; Sagae S; Kudo R; Hacker NF, 1999, 'Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell lines', Journal of Obstetrics and Gynaecology Research, vol. 25, pp. 23 - 27, http://dx.doi.org/10.1111/j.1447-0756.1999.tb01117.x

Ishioka SI; Van Haaften-Day C; Sagae S; Kudo R; Hacker NF, 1999, 'Effects of interleukin-6 (IL-6) on chemotherapy-induced apoptosis in human ovarian cancer cell lines', International Journal of Clinical Oncology, vol. 4, pp. 84 - 89, http://dx.doi.org/10.1007/s101470050032

Philip J; Lickiss N; Grant PT; Hacker NF, 1999, 'Corticosteroids in the management of bowel obstruction on a gynecological oncology unit', Gynecologic Oncology, vol. 74, pp. 68 - 73, http://dx.doi.org/10.1006/gyno.1999.5406

Alper O; Hacker NF; Cho-Chung YS, 1999, 'Protein kinase A-Iα subunit-directed antisense inhibition of ovarian cancer cell growth: Crosstalk with tyrosine kinase signaling pathway', Oncogene, vol. 18, pp. 4999 - 5004, http://dx.doi.org/10.1038/sj.onc.1202830

Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC, 1999, 'Hormone replacement therapy and risk of epithelial ovarian cancer', British Journal of Cancer, vol. 81, pp. 559 - 563, http://dx.doi.org/10.1038/sj.bjc.6690731

Hyde SE; Hacker NF, 1999, 'Vaginal reconstruction in the fibrotic pelvis', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 39, pp. 448 - 453

Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF, 1999, 'Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection: A pilot study', Cancer, vol. 86, pp. 2059 - 2065, http://dx.doi.org/10.1002/(SICI)1097-0142(19991115)86:10<2059::AID-CNCR25>3.0.CO;2-X

Averette HE; Austin JM; Boronow RC; Lewis JL; Mikuta JJ; Morrow CP; Nelson JH; Underwood PB; Berkowitz RS; Curry SL, 1998, 'Introductory remarks', ONCOLOGY-NEW YORK, vol. 12, pp. 119 - 119, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072471900025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hacker NF, 1998, 'Organization of gynecological cancer care: A time for change', International Journal of Gynecological Cancer, vol. 8, pp. 1 - 5, http://dx.doi.org/10.1046/j.1525-1438.1998.97111.x

Hacker NF, 1998, 'Current management of early vulvar cancer', Annals of the Academy of Medicine Singapore, vol. 27, pp. 688 - 692

Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF, 1998, 'p53 Protein overexpression: A strong prognostic factor in uterine papillary serous carcinoma', Gynecologic Oncology, vol. 71, pp. 59 - 63, http://dx.doi.org/10.1006/gyno.1998.5113

Campion MJ; Hacker NF, 1998, 'Vulvar intraepithelial neoplasia and carcinoma', Seminars in Cutaneous Medicine and Surgery, vol. 17, pp. 205 - 212, http://dx.doi.org/10.1016/S1085-5629(98)80015-1

Bancher-Todesca D; Neunteufel W; Williams KE; Prainsack D; Breitenecker G; Friedlander ML; Hacker NF, 1998, 'Influence of postoperative treatment on survival in patients with uterine papillary serous carcinoma', Gynecologic Oncology, vol. 71, pp. 344 - 347, http://dx.doi.org/10.1006/gyno.1998.5202

Hacker NF, 1996, 'Cytoreduction for advanced ovarian cancer in perspective', International Journal of Gynecological Cancer, vol. 6, pp. 159 - 160, http://dx.doi.org/10.1046/j.1525-1438.1996.06020159.x

Van Der Velden J; Hacker NF, 1996, 'Prognostic factors in squamous cell cancer of the vulva and the implications for treatment', Current Opinion in Obstetrics and Gynecology, vol. 8, pp. 3 - 7

Van Haaften-Day C; Russell P; Boyer CM; Kerns BJM; Wiener JR; Jensen DN; Bast RC; Hacker NF, 1996, 'Expression of cell regulatory proteins in ovarian borderline tumors', Cancer, vol. 77, pp. 2092 - 2098, http://dx.doi.org/10.1002/(SICI)1097-0142(19960515)77:10<2092::AID-CNCR19>3.0.CO;2-Q

Hacker NF, 1996, 'The management of early invasive carcinoma of the vulva', Israel Journal of Obstetrics and Gynaecology, pp. 1 - 5

Dew JE; Athanasatos P; Hacker NF, 1995, 'The Significance of Mild Squamous Atypia on Cytology', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 35, pp. 443 - 445, http://dx.doi.org/10.1111/j.1479-828X.1995.tb02164.x

Purdie D; Green A; Bain C; Siskind V; Ward B; Hacker N; Quinn M; Wright G; Russell P; Susil B, 1995, 'Reproductive and other factors and risk of epithelial ovarian cancer: An australian case‐control study', International Journal of Cancer, vol. 62, pp. 678 - 684, http://dx.doi.org/10.1002/ijc.2910620606

Gitsch G; Friedlander ML; Wain GV; Hacker NF, 1995, 'Uterine papillary serous carcinoma. A clinical study', Cancer, vol. 75, pp. 2239 - 2243, http://dx.doi.org/10.1002/1097-0142(19950501)75:9<2239::AID-CNCR2820750908>3.0.CO;2-7

Nicklin JL; Hacker NF; Heintze SW; Van Eijkeren M; Durham NJ, 1995, 'An anatomical study of inguinal lymph node topography and clinical implications for the surgical management of vulval cancer', International Journal of Gynecological Cancer, vol. 5, pp. 128 - 133, http://dx.doi.org/10.1046/j.1525-1438.1995.05020128.x

Gitsch G; Hanzal E; Jensen D; Hacker NF, 1995, 'Endometrial cancer in premenopausal women 45 years and younger', Obstetrics and Gynecology, vol. 85, pp. 504 - 508, http://dx.doi.org/10.1016/0029-7844(95)00001-8

Hacker NF, 1995, 'Systematic Pelvic and Paraaortic Lymphadenectomy for Advanced Ovarian Cancer-Therapeutic Advance or Surgical Folly?', Gynecologic Oncology, vol. 56, pp. 325 - 327, http://dx.doi.org/10.1006/gyno.1995.1058

Van der velden J; Gitsch G; Wain GV; Friedlander ML; Hacker NF, 1995, 'Tamoxifen in patients with advanced epithelial ovarian cancer', International Journal of Gynecological Cancer, vol. 5, pp. 301 - 305, http://dx.doi.org/10.1046/j.1525-1438.1995.05040301.x

Hacker NF; Wain GV; Nicklin JL, 1995, 'Resection of bulky positive lymph nodes in patients with cervical carcinoma', International Journal of Gynecological Cancer, vol. 5, pp. 250 - 256, http://dx.doi.org/10.1046/j.1525-1438.1995.05040250.x

Gitsch G; Van Eijkeren M; Hacker NF, 1995, 'Surgical therapy of vulvar cancer in pregnancy', Gynecologic Oncology, vol. 56, pp. 312 - 315, http://dx.doi.org/10.1006/gyno.1995.1053

Gitsch G; Jensen DN; Hacker NF, 1995, 'A combined abdominoperineal approach for the resection of a large giant cell tumor of the sacrum', Gynecologic Oncology, vol. 57, pp. 113 - 116, http://dx.doi.org/10.1006/gyno.1995.1107

Nicklin JL; Hacker NF; Heintze SW; Van Eijkeran M; Durham NJ, 1995, 'An anotomical study of inguinal lymph node topography and clinical implications for the surgical management of vulval cancer', International Journal of Gynecological Cancer, pp. 128 - 133

Gitch G; Hacker NF; Hanzal E; Jensen DN, 1995, 'Endometrial cancer in women under 45 years and younger', Obstetrics and Gynecology, pp. 504 - 508

Nicklin JL; van Eijkeren M; Athanasatos P; Wain GV; Hacker NF, 1994, 'A Comparison of Ovarian Cyst Aspirate Cytology and Histology. The Case Against Aspiration of Cystic Pelvic Masses', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 34, pp. 546 - 549, http://dx.doi.org/10.1111/j.1479-828X.1994.tb01107.x

van der Velden J; Hacker NF, 1994, 'Update on vulvar carcinoma.', Cancer treatment and research, vol. 70, pp. 101 - 119

Segelov E; Campbell J; Ng M; Tattersall M; Rome R; Free K; Hacker N; Friedlander ML, 1994, 'Cisplatin-based chemotherapy for ovarian germ cell malignancies: The Australian experience', Journal of Clinical Oncology, vol. 12, pp. 378 - 384, http://dx.doi.org/10.1200/JCO.1994.12.2.378

Allen DG; Baak J; Belpomme D; Berek JS; Bertelsen K; ten Bokkel Huinink WW; van der Burg ME; Calvert AH; Conte PF; Dauplat J, 1993, 'Advanced epithelial ovarian cancer: 1993 consensus statements.', Ann Oncol, vol. 4 Suppl 4, pp. 83 - 88, http://dx.doi.org/10.1093/annonc/4.suppl_4.s83

Trimbos JB; Hacker NF, 1993, 'The case against aspirating ovarian cysts', Cancer, vol. 72, pp. 828 - 831, http://dx.doi.org/10.1002/1097-0142(19930801)72:3<828::AID-CNCR2820720331>3.0.CO;2-T

Wain GV; Farnsworth A; Hacker NF, 1993, 'Cervical carcinoma after negative pap smears: Evidence against rapid-onset cancers', Obstetrical and Gynecological Survey, vol. 48, pp. 343 - 345

Proietto A; Hacker NF, 1993, 'Intraperitoneal interferon-alpha-2b for patients with no macroscopic disease following second-look laparotomy', International Journal of Gynecological Cancer, vol. 3, pp. 324 - 328, http://dx.doi.org/10.1046/j.1525-1438.1993.03050324.x

Hacker NF; Van Der Velden J, 1993, 'Conservative management of early vulvar cancer', Cancer, vol. 71, pp. 1673 - 1677, http://dx.doi.org/10.1002/cncr.2820710436

Hacker NF; Van der Burg MEL, 1993, 'Debulking and intervention surgery', Annals of Oncology, vol. 4, http://dx.doi.org/10.1093/annonc/4.suppl_4.S17

Hacker NF; Van der Burg MEL, 1993, 'Debulking and intervention surgery', Annals of Oncology, vol. 4, http://dx.doi.org/10.1093/annonc/4.suppl_4.S17

Wain GV; Farnsworth A; Hacker NF, 1992, 'Cervical carcinoma after negative pap smears: Evidence against rapid-onset cancers', International Journal of Gynecological Cancer, vol. 2, pp. 318 - 322, http://dx.doi.org/10.1046/j.1525-1438.1992.02060318.x

Wain GV; Farnsworth A; Hacker NF, 1992, 'The Papanicolaou smear histories of 237 patients with cervical cancer', Medical Journal of Australia, vol. 157, pp. 14 - 16

Berek JS; Heaps JM; Fu YS; Juillard GJF; Hacker NF, 1991, 'Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva', Gynecologic Oncology, vol. 42, pp. 197 - 201, http://dx.doi.org/10.1016/0090-8258(91)90345-6

Hacker NF, 1990, 'Surgery for Gynaecological Cancer: Results Since the Introduction of Radical Operations', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 30, pp. 24 - 28, http://dx.doi.org/10.1111/j.1479-828X.1990.tb03189.x

Wain GV; Hacker NF, 1990, 'Pittfalls in the screening and early diagnosis of cervical cancer', Current Opinion in Obstetrics and Gynecology, vol. 2, pp. 74 - 79

Farnsworth A; Hacker NF, 1990, 'Pathology of the vulva', Current Opinion in Obstetrics and Gynecology, vol. 2, pp. 448 - 455

Lawton FG; Hacker NF, 1990, 'Surgery for invasive gynecologic cancer in the elderly female population', Obstetrics and Gynecology, vol. 76, pp. 287 - 289

Binder SW; Huang I; Fu YS; Hacker NF; Berek JS, 1990, 'Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma', Gynecologic Oncology, vol. 37, pp. 9 - 16, http://dx.doi.org/10.1016/0090-8258(90)90298-Y

Heaps JM; Fu YS; Montz FJ; Hacker NF; Berek JS, 1990, 'Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva', Gynecologic Oncology, vol. 38, pp. 309 - 314, http://dx.doi.org/10.1016/0090-8258(90)90064-R

Hacker NF, 1990, 'Current treatment of small vulvar cancers.', Oncology (Williston Park, N.Y.), vol. 4, pp. 21 - 33

Lawton FG; Hacker NF, 1989, 'Sex and the elderly (I)', British Medical Journal, vol. 299, pp. 1279

Pretorius RG; Eisenkop S; Berek JS; Hacker NF; Ashikaga T; Knox RM; Lagasse LD, 1989, 'Utilization of a murine model to optimize volume and dwell time of intraperitoneal cisplatin', Gynecologic Oncology, vol. 34, pp. 66 - 69, http://dx.doi.org/10.1016/0090-8258(89)90109-1

Hacker NF, 1989, '6 Controversial aspects of cytoreductive surgery in epithelial ovarian cancer', Bailliere's Clinical Obstetrics and Gynaecology, vol. 3, pp. 49 - 57, http://dx.doi.org/10.1016/S0950-3552(89)80041-0

BEREK JS; HATCH KD; HACKER NF; YOUNG RC, 1988, 'UTERINE CORPUS AND CERVICAL-CANCER', CURRENT PROBLEMS IN CANCER, vol. 12, pp. 65 - 129, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988N187000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dauplat J; Nieberg RK; Philippe A; Hacker NF, 1988, 'Changes in the histocytological grading of epithelial ovarian carcinoma following treatment', International Journal of Gynecological Pathology, vol. 7, pp. 12 - 22, http://dx.doi.org/10.1097/00004347-198803000-00002

Sagae S; Berek JS; Fu YS; Chang N; Dauplat J; Hacker NF, 1988, 'Peritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: Quantitation of malignant cells and response', Obstetrics and Gynecology, vol. 72, pp. 782 - 788

Brand E; Berek JS; Hacker NF, 1988, 'Controversies in the management of cergvical adenocarcinoma', Obstetrics and Gynecology, vol. 71, pp. 261 - 269

Berek JS; Hacker NF; Hatch KD; Young RC, 1988, 'Uterine corpus and cervical cancer.', Current problems in cancer, vol. 12, pp. 61 - 131

Reimnitz C; Brand E; Nieberg RK; Hacker NF, 1988, 'Malignancy arising in endometriosis associated with unopposed estrogen replacement', Obstetrics and Gynecology, vol. 71, pp. 444 - 447

Hacker NF, 1988, '2 Clinical and operative staging of cervical cancer', Bailliere's Clinical Obstetrics and Gynaecology, vol. 2, pp. 747 - 759, http://dx.doi.org/10.1016/S0950-3552(98)80004-7

Cochran SD; Hacker NF; Wellisch DK; Berek JS, 1987, 'Sexual functioning after treatment for endometrial cancer', Journal of Psychosocial Oncology, vol. 5, pp. 47 - 61, http://dx.doi.org/10.1300/J077v05n02_05

Brand E; Berek JS; Nieberg RK; Hacker NF, 1987, 'Rhabdomyosarcoma of the uterine cervix. Sarcoma botryoides', Cancer, vol. 60, pp. 1552 - 1560, http://dx.doi.org/10.1002/1097-0142(19871001)60:7<1552::AID-CNCR2820600724>3.0.CO;2-W

Dauplat J; Nieberg RK; Hacker NF, 1987, 'Central nervous system metastases in epithelial ovarian carcinoma', Cancer, vol. 60, pp. 2559 - 2562, http://dx.doi.org/10.1002/1097-0142(19871115)60:10<2559::AID-CNCR2820601035>3.0.CO;2-7

Sedlis A; Homesley H; Bundy BN; Marshall R; Yordan E; Hacker N; Lee JH; Whitney C, 1987, 'Positive groin lymph nodes in superficial squamous cell vulvar cancer. A gynecologic oncology group study', American Journal of Obstetrics and Gynecology, vol. 156, pp. 1159 - 1164, http://dx.doi.org/10.1016/0002-9378(87)90132-3

Fu YS; Hall TL; Berek JS; Hacker NF; Reagen JW, 1987, 'Prognostic significance of DNA ploidy and morphometric analyses of adenocarcinoma of the uterine cervix', Analytical and Quantitative Cytology and Histology, vol. 9, pp. 17 - 24

Dauplat J; Hacker NF; Nieberg RK; Berek JS; Rose TP; Sagae S, 1987, 'Distant metastases in epithelial ovarian carcinoma', Cancer, vol. 60, pp. 1561 - 1566, http://dx.doi.org/10.1002/1097-0142(19871001)60:7<1561::AID-CNCR2820600725>3.0.CO;2-V

Hacker NF; Berek JS; Pretorius RG; Juliazuckerman; Eisenkop S; Lagasse LD, 1987, 'Intraperitoneal cis-platinum as salvage therapy for refractory epithelial ovarian cancer', Obstetrics and Gynecology, vol. 70, pp. 759 - 764

Cochran SD; Hacker NF; Berek J, 1986, 'Correlates of delay in seeking treatment for endometrial cancer', Journal of Psychosomatic Obstetrics and Gynecology, vol. 5, pp. 245 - 252, http://dx.doi.org/10.3109/01674828609016764

Heintz APM; Hacker NF; Berek JS; Rose TP; Munoz AK; Lagasse LD, 1986, 'Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity', Obstetrics and Gynecology, vol. 67, pp. 783 - 788, http://dx.doi.org/10.1097/00006250-198606000-00007

Smotkin D; Berek JS; Fu YS; Hacker NF; Major FJ; Wettstein FO, 1986, 'Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix', Obstetrics and Gynecology, vol. 68, pp. 241 - 244

Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD, 1986, 'Intraperitoneal recombinant α-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: A gynecologic oncology group study', Seminars in Oncology, vol. 13, pp. 61 - 71

Heintz APM; Hacker NF; Lagasse LD, 1985, 'Epidemiology and etiology of ovarian cancer: A review', Obstetrics and Gynecology, vol. 66, pp. 127 - 135

Berek JS; Hacker NF; Fu YS; Sokale JR; Leuchter RC; Lagasse LD, 1985, 'Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival', Obstetrics and Gynecology, vol. 65, pp. 46 - 51

Hacker NF; Berek JS; Michelle Burnison C; Heintz APM; Juillard GJF; Lagasse LD, 1985, 'Whole abdominal radiation as salvage therapy for epithelial ovarian cancer', Obstetrics and Gynecology, vol. 65, pp. 60 - 65

Berek JS; Knapp RC; Hacker NF; Lichtenstein A; Jung T; Spina C; Obrist R; Griffiths CT; Berkowitz RS; Parker L, 1985, 'Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum', American Journal of Obstetrics and Gynecology, vol. 152, pp. 1003 - 1010, http://dx.doi.org/10.1016/0002-9378(85)90548-4

Berek JS; Hacker NF; Lichtenstein A; Jung T; Spina C; Knox RM; Brady J; Greene T; Ettinger LM; Lagasse LD, 1985, 'Intraperitoneal recombinant α2-interferon for 'salvage' immunotherapy in persistent epithelial ovarian cancer', Cancer Treatment Reviews, vol. 12, pp. 23 - 32

Berek JS; Hacker NF; Jung T; Knox RM; Greene T; Ettinger LM; Lagasse LD; Lichtenstein A; Soina C; Zighelboim J, 1985, 'Intraperitoneal Recombinant α-Interferon for “Salvage” Lmmunotherapy in Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study', Cancer Research, vol. 45, pp. 4447 - 4453

Berek JS; Hacker NF; Lagasse LD, 1984, 'Vaginal reconstruction performed simultaneously with pelvic exenteration', Obstetrics and Gynecology, vol. 63, pp. 318 - 323

Hacker NF; Berek JS; Lagasse LD; Nieberg RK; Leuchter RS, 1984, 'Individualization of treatment for stage i squamous cell vulvar carcinoma', Obstetrics and Gynecology, vol. 63, pp. 155 - 162

Cantrell JL; Lichtenstein AK; Berek JS; Hacker NF; Knox RM; Nieberg RK; Poth T; Elashoff RM; Lagasse LD; Zighelboim J, 1984, 'Immunotherapy with Biochemically Dissociated Fractions of Propionibacterium acnes in a Murine Ovarian Cancer Model', Cancer Research, vol. 44, pp. 1871 - 1875

Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK, 1984, 'Second-look laparotomy in stage iii epithelial ovarian cancer: Clinical variables associated with disease status', Obstetrics and Gynecology, vol. 64, pp. 207 - 212

Leuchter RS; Townsend DE; Hacker NF; Pretorius RG; Lagasse LD; Wade ME, 1984, 'Treatment of vulvar carcinoma in situ with the CO2 laser', Gynecologic Oncology, vol. 19, pp. 314 - 322, http://dx.doi.org/10.1016/0090-8258(84)90198-7

Hacker NF; Berek JS; Juillard GJF; Lagasse LD, 1984, 'Preoperative radiation therapy for locally advanced vulvar cancer', Cancer, vol. 54, pp. 2056 - 2061, http://dx.doi.org/10.1002/1097-0142(19841115)54:10<2056::AID-CNCR2820541003>3.0.CO;2-L

Berek JS; Hacker NF; Lagasse LD, 1984, 'Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer', Obstetrics and Gynecology, vol. 64, pp. 715 - 720

Lichtenstein A; Berek J; Bast R; Spina C; Hacker N; Knapp RC; Zighelboim U, 1984, 'Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with corynebacterium parvum', Journal of Biological Response Modifiers, vol. 3, pp. 371 - 378

Berek JS; Bast RC; Lichtenstein A; Hacker NF; Spina CA; Lagasse LD; Knapp RC; Zighelboim J, 1984, 'Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer', Obstetrics and Gynecology, vol. 64, pp. 708 - 714

Andersen BL; Hacker NF, 1983, 'Psychosexual adjustment of gynecologic oncology patients: A proposed model for future investigation', Gynecologic Oncology, vol. 15, pp. 214 - 223, http://dx.doi.org/10.1016/0090-8258(83)90077-X

Berek JS; Hacker NF; Lagasse LD; Smith ML, 1983, 'Delayed vaginal reconstruction in the fibrotic pelvis following radiation or previous reconstruction', Obstetrics and Gynecology, vol. 61, pp. 743 - 748

Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins YL; DeLange RJ, 1983, 'Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva', Gynecologic Oncology, vol. 15, pp. 27 - 31, http://dx.doi.org/10.1016/0090-8258(83)90113-0

Hacker NF; Nieberg RK; Berek JS; Leuchter RS; Lucas WE; Tamimi HK; Nolan JF; Moore JG; Lagasse LD, 1983, 'Superficially invasive vulvar cancer with nodal metastases', Gynecologic Oncology, vol. 15, pp. 65 - 77, http://dx.doi.org/10.1016/0090-8258(83)90118-X

Hacker NF; Berek JS; Lagasse LD; Nieberg RK; Elashoff RM, 1983, 'Primary cytoreductive surgery for epithelial ovarian cancer', Obstetrics and Gynecology, vol. 61, pp. 413 - 420

Hacker NF; Berek JS; Lagasse LD; Leuchter RS; Moore JG, 1983, 'Management of regional lymph nodes and their prognostic influence in vulvar cancer', Obstetrics and Gynecology, vol. 61, pp. 408 - 412

Berek JS; Hacker NF; Lagasse LD; Nieberg RK; Elashoff RM, 1983, 'Survival of patients following secondary cytoreductive surgery in ovarian cancer', Obstetrics and Gynecology, vol. 61, pp. 189 - 193

Ford LC; Berek JS; Lagasse LD; Hacker NF; Heins Y; Esmailian F; Leuchter RS; DeLange RJ, 1983, 'Estrogen and progesterone receptors in ovarian neoplasms', Gynecologic Oncology, vol. 15, pp. 299 - 304, http://dx.doi.org/10.1016/0090-8258(83)90047-1

Berek JS; Hacker NF; Lagasse LD; Leuchter RS, 1982, 'Lower urinary tract resection as part of cytoreductive surgery for ovarian cancer', Gynecologic Oncology, vol. 13, pp. 87 - 92, http://dx.doi.org/10.1016/0090-8258(82)90012-9

Leuchter RS; Lagasse LD; Hacker NF; Berek JS, 1982, 'Management of postexenteration perineal hernias by myocutaneous axial flaps', Gynecologic Oncology, vol. 14, pp. 15 - 22, http://dx.doi.org/10.1016/0090-8258(82)90046-4

Berek JS; Lagasse LD; Hacker NF; Leuchter RS, 1982, 'Levator ani transposition for anal incompetence secondary to sphincter damage', Obstetrics and Gynecology, vol. 59, pp. 108 - 112

Hacker NF; Berek JS; Lagasse LD; Charles EH; Savage EW; George Moore J, 1982, 'Carcinoma of the cervix associated with pregnancy', Obstetrics and Gynecology, vol. 59, pp. 735 - 747

Leuchter RS; Petrilli ES; Dwyer RM; Hacker NF; Castaldo TW; Lagasse LD, 1982, 'Nd:Yag laser therapy of rectosigmoid bleeding due to radiation injury', Obstetrics and Gynecology, vol. 59, pp. 65S - 67S

Leuchter RS; Hacker NF; Voet RL; Berek JS; Townsend DE; Lagasse LD, 1982, 'Primary carcinoma of the bartholin gland: A report of 14 cases and review of the literature', Obstetrics and Gynecology, vol. 60, pp. 361 - 368

Berek JS; Hacker NF; Lagasse LD, 1982, 'Recent progress in the treatment of epithelial ovarian malignancy', Western Journal of Medicine, vol. 137, pp. 273 - 277

Pretorius RG; Hacker NF; Berek JS, 1982, 'Intraperitoneal cis-platinum in patients with ovarian carcinoma', Proceedings of the American Society of Clinical Oncology, vol. Vol. 1

Berek JS; Castaldo TW; Hacker NF; Petrilli ES; Lagasse LD; Moore JG, 1981, 'Adenocarcinoma of the uterine cervix', Cancer, vol. 48, pp. 2734 - 2741, http://dx.doi.org/10.1002/1097-0142(19811215)48:12<2734::AID-CNCR2820481230>3.0.CO;2-N

Khoo SK; Hacker N; Chang A, 1980, 'An incremental-dose combined oestrogen-progestogen oral contraceptive: effects on body weight, blood pressure, and biochemical parameters.', Aust N Z J Obstet Gynaecol, vol. 20, pp. 172 - 176, http://dx.doi.org/10.1111/j.1479-828x.1980.tb02901.x

Jacob F; Anugraham M; Pochechueva T; Tse BW-C; Alam S; Guertler R; Bovin NV; Fedier A; Hacker NF; Huflejt ME, 2015, 'Natural anti-glycan IgM recognize P1 glycosphingolipid expressed on ovarian cancer cells', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Seattle, WA, presented at 10th Biennial Ovarian Cancer Research Symposium, Seattle, WA, 08 - 09 September 2014, http://dx.doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-BIOL-1322

Ius YM; Hacker NF; Campion M; Tan J, 2014, 'THE ROLE OF HPV TESTING AS A TEST OF CURE: A TEN YEAR STUDY', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 747 - 747, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966501133&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz V, 2014, 'TRANSCRIPTIONAL SILENCING OF FORSSMAN SYNTHETASE IS REGULATED BY DNA METHYLATION IN OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 238 - 239, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob F; Anugraham M; Pochechueva T; Tse B; Alam S; Guertler R; Bovin NV; Fedier A; Hacker NF; Huflejt ME, 2014, 'P1 GLYCOSPHINGOLIPID IS AN OVARIAN CANCER-ASSOCIATED CARBOHYDRATE ANTIGEN AND ENHANCES CELL MIGRATION', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 240 - 241, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob F; Anugraham M; Shahidul A; Bovin N; Packer N; Hacker N; Heinzelmann-Schwarz V, 2013, 'P1 glycosphingolipid is expressed on ovarian cancer cells recognized by naturally occurring anti-P1 antibodies', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1078-0432.OVCA13-B23

Jacob F; Goldstien D; Pochechueva T; Tse BWC; Bovin NV; Hufleji ME; Hacker NH; Heinzelmann-Schwarz V, 2012, 'Anti-glycan antibodies in epithelial ovarian cancer', in INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS PUBL LTD, pp. S29 - S29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310651600099&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tse BWC; Jacob F; Pochechueva T; Nixdorf S; Fedier A; Huflejt M; Bovin N; Fink DA; Hacker NF; Heinzelmann-Schwarz VA, 2012, 'Anti-glycan IgM and IgG antibodies as new biomarkers for serous ovarian cancers', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.AM2012-517

Barlow EL; Parmenter G; Hacker NF; Hussain R, 2011, 'WOMEN'S PERCEPTIONS OF CHANGES TO SEXUALITY AND BODY IMAGE FOLLOWING SURGICAL TREATMENT FOR EARLY STAGE VULVAR CANCER', in JOURNAL OF SEXUAL MEDICINE, WILEY-BLACKWELL, pp. 264 - 265, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291345300723&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thigpen JT; Bertelsen K; Eisenhauer EA; Hacker NF; Lund B; Sessa C, 1993, 'Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy.', in Ann Oncol, England, pp. 35 - 40, England, http://dx.doi.org/10.1093/annonc/4.suppl_4.s35